Newly Identified Protein Pathway May Help Explain Age-Related Cognitive Decline

A new study has identified a protein pathway that may play a key role in age-related cognitive decline by protecting the blood-brain barrier (BBB), the brain's essential defense system. The findings suggest that deterioration of this protective barrier may contribute directly to memory loss, anxiety, and declining cognitive function with age.

The research, led by Andrew A. Pieper, MD, PhD, and colleagues from University Hospitals, Case Western Reserve University, and the Louis Stokes Cleveland VA Medical Center, was published in the Proceedings of the National Academy of Sciences.

The blood-brain barrier is formed by tightly connected endothelial cells that line the brain's blood vessels. These cells act as a selective barrier, preventing harmful substances from entering the brain while supporting nutrient delivery, waste removal, and proper blood flow to active brain regions. Although BBB function is known to decline with age, the underlying molecular mechanisms have remained unclear.

The researchers identified the protein KLF4 as a critical regulator of BBB integrity. Produced by endothelial cells, KLF4 levels naturally decrease with aging. Using advanced two-photon microscopy and mouse models, the team found that accelerated loss of KLF4 led to earlier breakdown of the BBB, reduced brain microvessels, impaired blood flow regulation, and increased leakage across the barrier.

These vascular changes triggered oxidative stress, neuroinflammation, neuronal damage, anxiety-like behavior, and cognitive impairment—hallmarks typically associated with much older brains.

"Loss of endothelial cell KLF4 accelerated every major feature of brain aging that we measured," said Dr. Pieper. "These findings suggest that therapies aimed at preserving or restoring KLF4 function could help protect the blood-brain barrier and reduce age-related cognitive decline."

To further understand the mechanism, the researchers performed single-cell RNA sequencing, revealing widespread disruptions in genes involved in immune regulation and BBB maintenance following KLF4 loss. These molecular changes help explain how declining KLF4 contributes to multiple aspects of brain aging.

The study identifies KLF4 as a promising therapeutic target for future neuroprotective strategies. Ongoing research will focus on understanding why KLF4 levels decline with age and whether restoring its activity can preserve BBB function and help slow cognitive decline in aging populations.

Source: https://scitechdaily.com/scientists-have-identified-a-key-driver-of-age-related-cognitive-decline/